small molecule

VERQUVO

VERICIGUAT

Loss of exclusivityNovember 2032latest FDA-listed patent expiry

CompanyMERCK SHARP AND DOHME LLC

Drug detail

Brand name	VERQUVO
Active ingredient	VERICIGUAT
Strength	2.5MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	January 2021
Marketing status	RX

Listed patents

Patent	Expires	Type
9604948	November 2032	substance, product
9993476	May 2031	use U-3062
8921377	May 2031	use U-3062
11439642	May 2031	use U-3062
10736896	May 2031	substance, product
8420656	May 2031	substance, product

Regulatory exclusivity

Code	Expires
D-198	January 2029
NCE	January 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from MERCK SHARP AND DOHME LLC